Dr. Chapa’s OBGYN Clinical Pearls
Hyst + BSO for BRCA Risk Reduction?
Feb 24, 2026
· 26m
<p>Approximately 5–10% of all breast cancers are hereditary, and among those, BRCA1 and BRCA2 mutations are responsible for about 60% of cases. Yet, overall, only about 1-2% of all breast cancers in the general population are caused by BRCA mutations. Once childbearing is complete, the NCCN recommends risk-reducing BSO in patients carrying these mutations. But what about the uterus? Since childbearing is complete, and the ovaries are now removed, the sole purpose of the uterus- which is to initiate, nourish, …
ʻAʻole i kākau ʻia kēia ʻanuʻu
Hoʻohana i STT.ai e hoʻololi i kēia ʻāpana me AI. E loaʻa i ka huaʻōlelo pololei me ka ʻike ʻana i ka mea kākau, nā manawa, a me ka hoʻouna ʻana i nā ʻano like ʻole.
Ka hōʻike leo
Ka manawa o ka pae hua'ōlelo
Hoʻouna i ka SRT, TXT, JSON